Stock is down bigly today. -10%
Stifel maintains Hold on TransMedics stock amid revenue concerns By Investing.com
My search turned up the following pressures on the stock price:
- Fewer available hearts available by fentanyl/opiod overdoses (cases are down)
- GM pressure due to air support services spending
- Growth projections down to 20-25%
- Analyst perception that full year guidance is aggressive.
Adding here is not the worst spot. TDMX is definitely in a channel. Low ball orders will catch some rebound unless the next report is awful. (I don’t foresee any surprises there)
3 Likes
nice update, thx.
what sucks is I was close to banking profits earlier this week around $79, and moving into TTD or elsewhere.
back to holding for a bit. probably have to wait thru ER now, and hope for positive report.
enjoy weekend all!
Dreamer
I just have a hard time seeing the business of transporting organs for transplants being that big of a business. Good luck to you guys though!
1 Like
The business model has always kept me cautious, too.
Not wrong, but will point out that opioid abuse has been declining since 2021/2022. The bigger issues out there affecting teens to 40 yo’s still exist- alcohol abuse and trauma.
with trauma arguably increasing nationally.
Plus with healthcare costs rising + healthcare being taken away = more sick folks avoiding hospitals = slightly higher increase in avoidable deaths.
Yes, healthcare and transplants are somewhat politically driven.
2 Likes